Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling

Publication date: Available online 22 May 2020Source: Molecular and Cellular ProbesAuthor(s): Ting Sun, Yunyong Liu, Mengdan Li, Huihui Yu, Haozhe Piao
Source: Molecular and Cellular Probes - Category: Molecular Biology Source Type: research